Cancer incidence among patients with AS in Sweden 1965–95
Observed cancers | SIR | 95% CI | |
---|---|---|---|
Sex | |||
Male | 262 | 1.08 | 0.96 to 1.22 |
Female | 63 | 0.92 | 0.71 to 1.18 |
Age at entry | |||
0–19 | 2 | 2.42 | 0.29 to 8.73 |
20–39 | 56 | 1.17 | 0.88 to 1.51 |
40–59 | 158 | 1.02 | 0.86 to 1.19 |
60- | 109 | 1.03 | 0.84 to 1.24 |
Attained age at cancer diagnosis (years) | |||
0–19 | 0 | – | – |
20–39 | 18 | 1.47 | 0.87 to 2.33 |
40–44 | 15 | 1.17 | 0.66 to 1.94 |
45–49 | 15 | 0.74 | 0.42 to 1.23 |
50–59 | 67 | 1.12 | 0.86 to 1.42 |
60- | 210 | 1.02 | 0.89 to 1.17 |
Follow up time (years) | |||
0–5 | 92 | 1.02 | 0.82 to 1.25 |
6–10 | 81 | 0.91 | 0.72 to 1.13 |
11–15 | 74 | 1.14 | 0.89 to 1.43 |
16– | 78 | 1.18 | 0.93 to 1.47 |
Time period | |||
1965–75 | 137 | 1.22 | 1.03 to 1.45 |
1976–85 | 129 | 0.90 | 0.75 to 1.07 |
1986–95 | 59 | 1.07 | 0.82 to 1.38 |
All cancers | 325 | 1.05 | 0.94 to 1.17 |